Press releases

  • 2020-02-05

    NeoDynamics AB (publ) full-year report 2019

    Summing up a productive 2019 Read more
  • 2020-02-03

    A clinical study performed at Karolinska Hospital with NeoDynamics’ new biopsy system, NeoNavia, has been accepted as an abstract by the Society for Breast Imaging (SBI) in the US.

    Associate professor Edward Azavedo has performed a retrospective study at Karolinska Hospital, where he analyzed tissue samples using NeoDynamics’ new biopsy system, NeoNavia. An abstract with the initial study results has been accepted by SBI for presentation at their annual meeting in Denver, April 16-19, 2020. Read more
  • 2020-01-28

    NeoDynamics AB (publ) receives notification of granted patent on biopsy instrument in China

    The expected announcement from the Chinese patent authority means that NeoDynamics´ unique biopsy device with front-loaded needle and integrated trocar, an important component of the NeoNavia® biopsy system is approved. The patent increases the protection of the NeoNavia biopsy system, which further strengthens the competitiveness. Read more
  • 2019-11-27

    NeoDynamics signs manufacturing agreement for NeoNavia

    NeoDynamics has signed an agreement with a world class contract manufacturer to prepare market introduction of the company’s new breast cancer biopsy system NeoNavia® and scale up production of the new biopsy probe models.  Read more
  • 2019-11-21

    NeoDynamics AB (publ) Third quarter Jul-Sep 2019

    During the third quarter NeoDynamics developed according to plan. After the end of the quarter the new version of NeoDynamics biopsy system NeoNavia received regulatory approval in the EU and attracted great interest at the annual British radiology congress. The convertible loan was subscribed to an amount of ca SEK 15 million. Read more
  • 2019-11-05

    For the first time in UK, a wider audience can get first-hand experience of the NeoNavia® micropulse biopsy system for breast cancer

    During the annual meeting of the British Society of Breast Radiology (BSBR) on 3-5th November in Bristol, radiologists get to gain first-hand experience using the innovative micropulse technology in meat models via a series of hands-on workshops arranged by NeoDynamics Read more
  • 2019-10-29

    NeoDynamics receives regulatory approval for new breast cancer biopsy system

    NeoDynamics today received confirmation from Intertek (Notified Body) that the improved version of the new system for breast cancer biopsy, NeoNavia, is accepted as an update to the already EU approved study version. The upgraded pulse biopsy system including three needle types, is added to the product list on the company’s EC certificate. Read more
  • 2019-09-16

    NeoDynamics recruits a country manager for Germany, Switzerland and Austria

    Renate Reiss takes over as Country Manager for NeoDynamics in the German-speaking countries in the EU, starting on 15 October. Renate has a broad international experience in product launches, from leading roles in the pharmaceutical industry. She will be responsible for the launch of NeoNavia, a brand new system for breast cancer tissue diagnosis. Read more
  • 2019-08-28

    NeoDynamics has secured financing through the issue of convertibles and calls for an Extraordinary General Meeting

    The Board of Directors of NeoDynamics AB (publ) ("NeoDynamics") or ("The Company") has decided to propose an issue of convertibles of up to SEK 15 million to strengthen the Company's cash and secure capital requirements prior to the start of production and clinical trials. The Board has therefore decided to convene an Extraordinary General Meeting on September 16. See attached notice (Swedish language) Read more
  • 2019-08-28

    NeoDynamics Half-year report 2019

    Approaching the market – registration in focus Read more